Paul Tudor Jones's RLAY Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 76,446 shares of Relay Therapeutics, Inc. (RLAY) worth $399,048, representing 0.00% of the portfolio. First purchased in 2020-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in RLAY, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2025, adding 76,446 shares. Largest reduction occurred in Q2 2025, reducing 83,158 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Relay Therapeutics (RLAY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Relay Therapeutics (RLAY) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2020 | +19,347 | New Buy | 19,347 | $42.59 |
| Q4 2020 | +23,939 | Add 123.73% | 43,286 | $41.56 |
| Q1 2021 | -43,286 | Sold Out | 0 | $0.00 |
| Q1 2022 | +33,922 | New Buy | 33,922 | $29.92 |
| Q2 2022 | -33,922 | Sold Out | 0 | $0.00 |
| Q3 2023 | +55,993 | New Buy | 55,993 | $8.41 |
| Q4 2023 | -24,679 | Reduce 44.08% | 31,314 | $11.01 |
| Q1 2024 | +34,127 | Add 108.98% | 65,441 | $8.30 |
| Q2 2024 | +709 | Add 1.08% | 66,150 | $6.52 |
| Q3 2024 | +14,533 | Add 21.97% | 80,683 | $7.08 |
| Q4 2024 | +5,674 | Add 7.03% | 86,357 | $4.12 |
| Q1 2025 | -3,199 | Reduce 3.70% | 83,158 | $2.62 |
| Q2 2025 | -83,158 | Sold Out | 0 | $0.00 |
| Q3 2025 | +76,446 | New Buy | 76,446 | $5.22 |
Paul Tudor Jones's Relay Therapeutics Investment FAQs
Paul Tudor Jones first purchased Relay Therapeutics, Inc. (RLAY) in Q3 2020, acquiring 19,347 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Relay Therapeutics, Inc. (RLAY) for 14 quarters since Q3 2020.
Paul Tudor Jones's largest addition to Relay Therapeutics, Inc. (RLAY) was in Q3 2025, adding 76,446 shares worth $399,048.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 76,446 shares of Relay Therapeutics, Inc. (RLAY), valued at approximately $399,048.
As of the Q3 2025 filing, Relay Therapeutics, Inc. (RLAY) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Relay Therapeutics, Inc. (RLAY) was 86,357 shares, as reported at the end of Q4 2024.